维普中文期刊产品整合服务
18篇 您的检索式:作者名="Clearfield MB"
    题名 作者 年代 出处 被引量
1C-reactive protein: a new risk assess- ment tool for cardiovascular disease 显示文摘Clearfield MB 2005J Am Os- teepath Assoc2005,195,9:1
2Overweight and obesity:the pathogenesis of cardiometabolic ris显示文摘Bray G A Clearfield MB Fintel D J 2009Clin Cornerstone2009,9,4:1
3C-Reactive Protein:A New Risk Assessment Tool for Cardiovascular Disease显示文摘Clearfield MB 2005J Am Osteopath Assoc2005,105,9:1
4C - reactive protein : a new risk assessment tool for cardiovascular disease 显示文摘Clearfield MB 2005J Am Osteepath Assoc2005,195,9:1
5C-reactive protein: a new risk assessment tool for cardiovascular disease 显示文摘Clearfield MB 2005J Am Osteopath Assoc2005,105,9:1
6C-reactive protein:a new risk assessment tool for cardiovascular disease显示文摘Clearfield MB 2005J Am Osteopath Assoc2005,105,9:1
7C-reactive proteina new risk assess- ment tool for cardiovascular disease显示文摘Clearfield MB 2005Am Osteopath Assoc2005,105,9:1
8Altering the pathophysiology of atherosclerosis:the multidimensional role of statins显示文摘Clearfield MB 2010J Am Osteopath Assoc2010,110,44:1
9C-reactive protein: a new risk assessment tool for cardiovascular disease显示文摘Clearfield MB 2005J Am Osteopath Assoc2005,105,9:1
10C - reactive protein:a new risk assessment tool for cardiovascular disease 显示文摘Clearfield MB 2005J Am Osteopath Assoc2005,105,9:1
11C-reactive protein:a new risk assessment tool for car- diovascular disease 显示文摘Clearfield MB 2005J Am Osteopath Assoc2005,105,9:1
12C-reactive protein:a new risk assessment tool for cardiovascular disease显示文摘Clearfield MB 2005J Am Osteopath Assoc2005,105,9:1
13C-reactive protein:a new risk assessment tool for cardiovascular disease显示文摘Clearfield MB 2005J Am Osteopath Assoc2005,105,9:1
14C-Reactive Protein: A new risk assessment tool for cardiovascular disease 显示文摘Clearfield MB 2005J Am Osteopath Assoc2005,105,9:1
15C-reactive protein:a new risk assessment tool for cardiovascular disease显示文摘CLEARFIELD MB 0,,09:1
16Overweight and obesity:the pathogenesis of cardiometabolic risk显示文摘Bray GA Clearfield MB Fintel DJ 2009Clin Cornerstone2009,9,4:1
17Comparison of the efficacy and safety of rosuvastatin 10 mg and atorvastatin 20 mg in high-risk patients with hypercholesterolemia-Pmspective study to evaluate the Use of Low doses of the Statins Atorvastatin and Rosnvastatin (PULSAR)显示文摘Clearfield MB Amerena J Bassand JP 2006Trials2006,,7:1
18C-reactive protein: a new risk assessment tool for cardiovascular disease显示文摘Clearfield MB 2005J Am Osteopath Assoc2005,105,9:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费